HRS-4642
N/A
Report date: 2026/05/28 20:00:21
NME
Base Information
Drug NameHRS-4642
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesShanghai Zhongshan HospitalFudan UniversityWest China Hospital Of Sichuan University +[6]
Inactive CompaniesN/A
Active Indications +[6]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A